Multiple Myeloma: evolving paradigm - Panel Discussion
Multiple Myeloma: evolving paradigm - Panel Discussion
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients
Advancements in paediatric Acute lymphoblastic leukemia management
Enhancing head and neck oncology: Key insights from the conference
Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC
Choosing 1st line TKI Wisely in patients with CML
Choosing Wisely in endometrial & cervix cancers: Medical therapy
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
ESMO 2024: Highlights and analysis
Immunotherapy resistance pathways investigated to tailor combination NSCLC therapy
ESMO 2024: Latest in bladder cancer - expert review
No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC